21 – 27 of 27
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- « previous
- 1
- 2
- 3
- next »
- 2003
-
Mark
Human mast cells decrease SLPI levels in type II - like alveolar cell model, in vitro.
(
- Contribution to journal › Article
- 2002
-
Mark
The presence of elafin, SLPI, IL1-RA and STNFalpha RI in head and neck squamous cell carcinomas and their relation to the degree of tumour differentiation.
(
- Contribution to journal › Article
- 2001
-
Mark
Secretory leukocyte protease inhibitor in punch biopsies from human colonic mucosa
(
- Contribution to journal › Article
- 1999
-
Mark
The effect of immediate-hypersensitivity reactions on the level of SLPI, granulocyte elastase, α1-antitrypsin, and albumin in nasal secretions, by the method of unilateral antigen challenge
(
- Contribution to journal › Article
-
Mark
Identification of SLPI (Secretory leukocyte protease inhibitor) in human mast cells using immunohistochemistry and in situ hybridisation
(
- Contribution to journal › Article
- 1998
-
Mark
IgE-mediated histamine release from nasal mucosa is inhibited by SLPI (secretory leukocyte protease inhibitor) to the level of spontaneous release
(
- Contribution to journal › Article
- 1994
-
Mark
Localisation of secretory leucocyte proteinase inhibitor mRNA in nasal mucosa
(
- Contribution to journal › Article
- « previous
- 1
- 2
- 3
- next »